Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60,893,283
-
Total 13F shares
-
1,824,977
-
Share change
-
0
-
Total reported value
-
$1,313,983
-
Price per share
-
$0.72
-
Number of holders
-
1
Institutional Holders of Equillium, Inc. - Common Stock (EQ) as of Q4 2023
As of 31 Dec 2023,
Equillium, Inc. - Common Stock (EQ) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
1,824,977 shares.
The largest 10 holders included
Decheng Capital LLC, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, Cota Capital Management, LLC, TANG CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, and Callan Capital, LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.